Resources
ÐÜèÊÓƵComment Letter on Interchangeable Biosimilar Applications
Comment Letter
ÐÜèÊÓƵsubmitted comments to FDA Commissioner Robert M. Califf, M.D., regarding interchangeable biosimilar applications.
Document Info
Published on Aug 20, 2024
Download and read the full Resource.